Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
La auditoría de la CES 2026 muestra un crecimiento del 4 % en la participación, gracias a la presencia de innovadores en Las Vegas
LC Sign Empowers Visually Impaired Students with Landmark Braille Project and Launches 'The Touchpoint Initiative'
Global Trade, Investment and Innovation Take Center Stage at the 56th Annual World Trade Centers Association Global Business Forum in Philadelphia
Geekplus Hits Profitability Milestone with 31.6% YoY Revenue Growth, Fueled by Embodied Intelligence-Driven Tech Innovation